Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bryant, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bryant, D. H.

Chest, Vol 88, 24-29, Copyright © 1985 by American College of Chest Physicians

ARTICLES

Nebulized ipratropium bromide in the treatment of acute asthma

DH Bryant

The aim of this study was to investigate the effects of nebulized ipratropium in patients with acute asthma in order to determine whether it augments the bronchodilator effect of a beta agonist drug. A total of 28 patients with acute asthma were randomly allocated to treatment every six hours with either 1 mg nebulized fenoterol (group A) or 1 mg fenoterol and 0.5 mg ipratropium (group B). There was no significant difference between the mean FEV1 of the two groups prior to treatment and increasing the dose of fenoterol from 1 mg to 2 mg did not increase the response. However the mean change in FEV1 after 48 hours (expressed as a percentage of the predicted maximal response) was 40.1 +/- 7.2 percent in group A and 54.3 +/- 9.2 percent in group B (p less than 0.005). It was concluded that the response of patients with acute asthma to fenoterol was significantly enhanced by the addition of the anticholinergic agent ipratropium bromide.


This article has been cited by other articles:


Home page
 Am J Health Syst PharmHome page
D. M. Schreck
Asthma pathophysiology and evidence-based treatment of severe exacerbations.
Am. J. Health Syst. Pharm., May 15, 2006; 63(10 Suppl 3): S5 - 13.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
G J Rodrigo and J A Castro-Rodriguez
Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis
Thorax, September 1, 2005; 60(9): 740 - 746.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
E. R. McFadden Jr.
Acute Severe Asthma
Am. J. Respir. Crit. Care Med., October 1, 2003; 168(7): 740 - 759.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. J. Rodrigo and C. Rodrigo
The Role of Anticholinergics in Acute Asthma Treatment* : An Evidence-Based Evaluation
Chest, June 1, 2002; 121(6): 1977 - 1987.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
G. J. RODRIGO and C. RODRIGO
First-Line Therapy for Adult Patients with Acute Asthma Receiving a Multiple-Dose Protocol of Ipratropium Bromide Plus Albuterol in the Emergency Department
Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 1862 - 1868.
[Abstract] [Full Text]

Home page
 CMAJHome page
Management of patients with asthma in the emergency department and in hospital
Can. Med. Assoc. J., November 1, 1999; 161(90111): s53 - 59.
[Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C. GUERIN, A. CHEVRE, P. DESSIRIER, T. PONCET, M.-H. BECQUEMIN, P. F. DEQUIN, C. LE GUELLEC, D. JACQUES, and G. FOURNIER
Inhaled Fenoterol-Ipratropium Bromide in Mechanically Ventilated Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., April 1, 1999; 159(4): 1036 - 1042.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
C Brophy, B Ahmed, S Bayston, A Arnold, D McGivern, and M Greenstone
How long should Atrovent be given in acute asthma?
Thorax, May 1, 1998; 53(5): 363 - 367.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by the American College of Chest Physicians.